Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 08:30 ET | Source: NetraMark Holdings Inc.

Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights

TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is...
June 12, 2025 08:13 ET | Source: NetraMark Holdings Inc.

NetraMark Founder Coauthors New Publication on AI/ML Use in Clinical Trials, Alongside Authors From Leading Global Regulatory Organizations

TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company...
May 30, 2023 07:01 ET | Source: GreenLight Biosciences

GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction

LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive...
April 12, 2023 06:59 ET | Source: GreenLight Biosciences

GreenLight Biosciences Releases Inaugural Sustainability Report

BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s...
February 28, 2023 09:21 ET | Source: Cytek Biosciences, Inc.

Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed

SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly...
February 01, 2023 07:20 ET | Source: GreenLight Biosciences

GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate

The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
November 16, 2022 17:00 ET | Source: Canada Foundation for Innovation

New funding announced to upgrade Canada’s biocontainment facilities

OTTAWA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The COVID-19 pandemic taught us that to tackle emerging global health issues countries must remain at the forefront of research. In Canada, this includes...
October 31, 2022 16:30 ET | Source: Cytek Biosciences, Inc.

Cytek® Biosciences Names Chris Williams Chief Operating Officer

Experienced Biotech, Pharmaceutical Industry Leader to Guide Operations Growth and Scalability FREMONT, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today...
May 02, 2022 13:08 ET | Source: Bragar Eagel & Squire

CALADRIUS BIOSCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CLBS and Encourages Investors to Contact the Firm

NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
April 28, 2021 10:00 ET | Source: Cytek Biosciences

Cytek® Biosciences Appoints Allen Poirson as Senior Vice President of Marketing and Corporate Development

FREMONT, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc., a leading life sciences technology company, today announced that Allen Poirson, Ph.D. has been appointed as the senior...